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Abstract In this study, we investigated the metabolite perme-
ability of isolated coupled Saccharomyces cerevisiae mitochon-
dria. The occurrence of a fumarate/malate antiporter activity
was shown. The activity differs from that of the dicarboxylate
carrier (which catalyses the succinate/malate antiport) in (a)
kinetics (Km and Vmax values are about 27 WM and 22 nmol
min31 mg protein31 and 70 WM and 4 nmol min31 mg protein31,
respectively), (b) sensitivity to inhibitors, (c) Ki for the
competitive inhibitor phenylsuccinate and (d) pH profiles.
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1. Introduction
Metabolite movement across the mitochondrial membrane
is essential to both mitochondrial and cytosolic metabolism.
Although many mitochondrial translocators have been iden-
ti¢ed, characterised and puri¢ed over the past 2 decades and
their activity reconstituted in arti¢cial liposomes [1,2], further
investigations are still required to ascertain the occurrence of
such translocators in mitochondria from di¡erent sources as
well as to elucidate the role of transport processes in cell
metabolism by the possible discovery of novel carriers.
In Saccharomyces cerevisiae mitochondria (SCM) the exis-
tence of certain carriers was reviewed [3] and their biochem-
istry investigated by swelling and isotopic techniques in iso-
lated organelles. More recently, the existence of about 30
mitochondrial proteins belonging to the carrier family has
been proposed in the light of genetic studies, with some of
them studied in in vitro systems (for references see [4]). How-
ever, in both cases, transport was studied under conditions in
which metabolism was either largely prevented or completely
absent. This prompted us to apply already developed spectro-
scopic techniques [5^9] to study transport in yeast mitochon-
dria in order to gain further insight into certain transport
features as well as to ¢nd out the existence of novel trans-
locators in mostly functional organelles. In particular, in the
light of the similarities found between our SCM and type 1
mitochondria [10], we undertook experimental work to study
the transport of citric cycle intermediates. In this regard, fu-
marate uptake by isolated yeast mitochondria has not been
reported yet, though several fumarate translocators have al-
ready been shown in mammalian mitochondria [5^8]. In this
paper we show that SCM contain the fumarate/malate anti-
porter separate from the dicarboxylate carrier [3,10].
2. Materials and methods
All reagents and enzymes were from Sigma (St. Louis, MO, USA)
except zymoliase (ICN) and Bacto yeast extract (Difco). Substrate
solution pH was adjusted to 7.20 by adding either Tris or HCl.
A strain (ATCC 18790) of S. cerevisiae was used. Cells were grown
aerobically for 16 h at 28‡C to a ¢nal A600nm equal to 2 in a semi-
synthetic medium containing 2% lactate as the carbon source and
containing, per litre, 3 g Bacto yeast extract, 1 g KH2PO4, 1 g NH4Cl,
0.5 g CaCl2W2H2O, 0.5 g NaCl, 0.6 g MgCl2, supplemented with 0.05%
glucose. Medium pH was adjusted to 5.5 with NaOH.
2.1. Isolation of mitochondria
Mitochondria were isolated and checked for their intactness as in
[11]. Mitochondrial proteins were measured as in [12]. In each experi-
ment, mitochondrial respiration was measured at 25‡C by a Clark
oxygen electrode in a 1.5 ml closed cell containing 0.6 M mannitol,
20 mM HEPES^Tris (pH 7.4), 10 mM potassium phosphate, 2 mM
MgCl2, 1 mM EDTA, 5 mg/ml bovine serum albumin. When added
with 0.5 mM ADP, SCM showed respiratory control index 2.05 þ 0.14
with 5 mM succinate used as a substrate. SCM showing a respiratory
control index lower than 1.9 were discarded.
2.2. Transport assay
In the extramitochondrial phase, either ATP or malate appearance
was revealed by using two NADP-linked detecting systems, namely
the ATP detecting system (ATP D.S.) consisting of 2.5 mM glucose,
0.2 mM NADP, 0.5 enzymatic units (e.u.) hexokinase-glucose 6-
phosphate dehydrogenase [9] and the malate detecting system
(M.D.S.), consisting of 0.25 mM NADP, 0.2 e.u. malic enzyme (pre-
viously dialysed against 100 mM Tris^HCl pH 7.20) [8]. In both cases,
the increase in NADPH concentration was followed £uorimetrically,
using a Perkin-Elmer LS-50B luminescence spectrometer with excita-
tion and emission wavelengths set at 334 and 456 nm, respectively.
The £uorescence change rates were obtained as the tangent to the
linear part of experimental curve and expressed as nmol NADP
reduced min31 mg mitochondrial protein31. In order to obtain a
quantitative measurement of the rate of NADP reduction, the £uo-
rimetric response was calibrated as in [13].
2.3. Computing
Where necessary, experimental plots were obtained by means of
Gra¢t software (Erithacus).
3. Results
First, in some sets of experiments, SCM were checked with
respect to their ability to synthesise ATP and to export it in
the extramitochondrial phase. This was done essentially as
already reported in rat liver mitochondria ([9] and Section
2). The control strength criterion [9] was applied by using
atractyloside as an inhibitor, thus showing that the measured
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rate of ATP appearance is a measure of the ADP/ATP anti-
port. The dependence of the rate of ATP e¥ux on the ADP
concentration was investigated in a Michaelis^Menten plot.
Saturation kinetics were found; Km and Vmax values were
about 20 WM and 56 nmol min31 mg protein31, respectively.
The nature of the inhibition of the ADP/ATP antiport on
the atractyloside concentration was studied as a Dixon plot.
Competitive inhibition was found with a Ki value for atractyl-
oside of about 0.04 WM. In order to distinguish between a
purely and a partially competitive inhibition, the same data
were plotted as the reciprocal of the fractional inhibition (i)
versus the reciprocal of the atractyloside concentration. A
partially competitive inhibition was found, as demonstrated
by the ordinate intercept values that are greater than 1 [14].
Using these mitochondria, the occurrence of the fumarate/
malate antiport, already reported in rat heat mitochondria, rat
liver mitochondria, rat brain mitochondria and rat kidney
mitochondria [5^8], was studied as reported in Section 2. Con-
sistently, the capability of externally added fumarate to cause
e¥ux of intramitochondrial malate from SCM was checked.
The malate concentration in a SCM suspension is negligible,
in fact no change in the £uorescence due to NADPH was
observed in the presence of malic enzyme and NADP. As
a result of fumarate addition to the mitochondria, an increase
of £uorescence was observed showing the appearance of ma-
late in the extramitochondrial phase. In agreement with [5^8],
a possible explanation for this ¢nding is that fumarate enters
mitochondria in exchange with a small amount of endogenous
malate via the putative fumarate/malate antiporter. Once in-
side the matrix, fumarate is hydrated to malate which in turn
leaves mitochondria in exchange with further fumarate. Con-
sistently, externally added thiocyanate (10 mM), a fumarase
non-competitive inhibitor [15] able to enter mitochondria [16],
was found to prevent malate e¥ux caused by fumarate addi-
tion (about 40% inhibition with 1 mM fumarate).
In order to ascertain whether the rate of NADPH £uores-
cence increase, caused by malate appearance, re£ects the ma-
late e¥ux outside mitochondria, rather than the intramito-
chondrial fumarase reaction, Triton X-100 (0.1%) was used.
Externally added Triton was found to cause an increase in the
rate of £uorescence due to fumarate addition, thus showing
that this is a measure of the transport occurring across the
mitochondrial membrane.
The dependence of the rate of fumarate/malate exchange on
increasing fumarate concentrations was investigated (Fig. 1).
Saturation kinetics were found with Km and Vmax values
about 27 WM and 22 nmol min31 mg mitochondrial protein31,
respectively. In the same experiment, the rate of malate e¥ux
due to the addition of succinate was also investigated as a
function of the substrate concentration. Saturation kinetics
were found with Km and Vmax values of about 70 WM and
4 nmol min31 mg mitochondrial protein31, respectively. The
triton experiment showed that the rate of malate appearance
due to externally added succinate re£ects the rate of succinate/
malate exchange due to the already reported dicarboxylate
carrier [10].
The nature of the phenylsuccinate inhibition on both fuma-
rate/malate and succinate/malate antiport was also investi-
gated as a Dixon plot (Fig. 2). A competitive inhibition was
found, with Ki values of about 6 and 1.3 mM, respectively.
The sensitivity of both fumarate/malate and succinate/malate
antiports to impermeable compounds, including 1 mM 1,2,3-
benzenetricarboxylate, 1 mM benzylmalonate, 1 mM butyl-
malonate, 0.1 mM K-cyanocinnamate, 0.1 mM N-ethylmale-
imide, 1 mM maleate, 10 mM methylfumarate and 10 mM
Fig. 1. Dependence of the malate e¥ux rate in the extramitochon-
drial phase on increasing substrate concentrations. Mitochondria
(0.2 mg protein) were incubated at 25‡C in 2 ml of standard me-
dium containing 0.6 M mannitol, 10 mM KCl, 1 mM MgCl2, 20
mM HEPES^Tris pH 7.20 and M.D.S. Fumarate (F) or succinate
(b) was added at the indicated concentrations and the rate of ma-
late appearance in extramitochondrial phase was monitored as re-
ported in Section 2.
Fig. 2. Dixon plot of the inhibition by phenylsuccinate on fumarate/
malate and succinate/malate antiports in SCM. Mitochondria (0.2
mg protein) were incubated in 2 ml of standard medium under the
same conditions reported in Fig. 1. The rate of malate appearance
in the extramitochondrial phase due to externally added fumarate
(A) and succinate (B) was measured as reported in Section 2 by us-
ing 0.02 mM (E), 0.1 mM (F), 0.35 mM (a) and 1 mM (b) respec-
tively, in either the absence or presence of phenylsuccinate, at the
indicated concentrations.
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phenylsuccinate, was investigated with 0.1 mM fumarate and
0.35 mM succinate used as substrates, in three di¡erent ex-
periments. As reported in Fig. 3, each translocator shows a
speci¢c inhibition pro¢le. In particular, externally added K-
cyanocinnamate, an inhibitor of the pyruvate carrier in mam-
malian mitochondria [17], proved to give 32 þ 3% inhibition
on fumarate/malate antiport without a¡ecting succinate/ma-
late antiport. Surprisingly, no inhibition was observed on fu-
marate/malate exchange in the presence of butylmalonate,
which inhibits the dicarboxylate carrier by 27 þ 3%. Moreover,
the thiol reagent mersalyl (up to 1 mM), which cannot be used
under the experimental conditions of Fig. 3, since it can in-
hibit malic enzyme reaction, was found to inhibit fumarate
uptake showing no e¡ect on succinate uptake, as measured
by swelling techniques (data not shown).
In another set of experiments, the pH dependence of the
two transport processes was investigated using substrate con-
centrations equal to 1 mM. pH pro¢les between pH 6.6 and 8
were found to di¡er from each other (Fig. 4): the rate of
succinate/malate was rather constant in the investigated pH
range, whereas the rate of fumarate/malate exchange was
about 23 nmol min31 mg protein31 in the range 6.6^7.2 and
decreased up to 9 for higher pH values.
4. Discussion
In this paper, we have studied the permeability properties of
isolated coupled SCM by means of a spectroscopic technique
already used to investigate mammalian mitochondrial trans-
locators [5^9]. We have chosen this technique because it al-
lows us to monitor mitochondrial transport in SCM with
active metabolism. It should be noted that the use of isolated
coupled mitochondria in transport studies leads to a better
investigation of both the role of transport in metabolism
and the occurrence of certain antiports which catalyse the
transport of extramitochondrial metabolites in exchange
with others which are synthesised in the matrix, following
counteranion uptake.
In this paper we show that, as reported for other mitochon-
dria [9,18], the rate of ATP production outside mitochondria
depends on the activity of the ADP/ATP translocator. More-
over, the Vmax of the ADP/ATP antiport, about 56 nmol
min31 mg protein31, is di¡erent from those measured in
mammalian and plant mitochondria under the same experi-
mental conditions: they were 20 nmol min31 mg protein31, 40
nmol min31 mg protein31 and 110 nmol min31 mg protein31
in rat liver mitochondria [9], in durum wheat mitochondria
[18] and in Solanum tuberosum cell mitochondria (Fratianni et
al, in preparation), respectively. Interestingly, the nature of
atractyloside inhibition was found to be partially competitive,
thus showing that atractyloside can bind to a saturable site of
the translocator, di¡erent from the ADP binding site.
Here we show that the fumarate/malate antiport takes place
in a carrier-mediated manner in isolated SCM. Widely used
criteria demonstrating the occurrence of carrier-mediated
transport were successfully applied, i.e. the hyperbolic de-
Fig. 3. Inhibition pro¢le of the fumarate/malate and succinate/malate antiports in SCM. Mitochondria (0.2 mg protein) were incubated in 2 ml
of standard medium under the same conditions reported in Fig. 1. The rate of malate appearance was measured as reported in Section 2 using
a concentration of fumarate equal to 0.1 mM and of succinate equal to 0.35 mM in either the absence or presence of the following inhibitors:
1 mM 1,2,3-benzenetricarboxylate (BTC), 1 mM butylmalonate (BUMA), 0.1 mM N-ethylmaleimide (NEM), 10 mM phenylsuccinate (PHE-
SUCC), 0.1 mM K-cyanocinnamate (CCN), 10 mM methylfumarate (METFUM), 1 mM maleate (MALE), 1 mM benzylmalonate (BEMA).
The inhibition percentages are the means of three di¡erent experiments.
Fig. 4. pH dependence of the fumarate/malate and succinate/malate
exchange rate in SCM. Mitochondria (0.2 mg protein) were incu-
bated, under the same conditions reported in Fig. 1, in 2 ml of the
standard medium whose pH was adjusted to the indicated values
with either Tris or HCl. Fumarate (F) and succinate (R) concentra-
tions were 1 mM. The standard deviation of the data was deter-
mined using the mean of three experiments.
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pendence on the substrate concentration and the inhibition by
compounds that cannot enter the mitochondrial matrix. Since
our SCM are rather similar to type 1 mitochondria [10], a
detailed investigation was carried out aimed at ascertaining
whether the fumarate/malate exchange is mediated by the di-
carboxylate translocator. The observed di¡erences in the Vmax
values, in the inhibitor and in the pH pro¢les and in the Ki
values for the competitive inhibitor phenylsuccinate (in this
case Ki re£ects a peculiar feature of the inhibitor^carrier in-
teraction), clearly show that the fumarate/malate and the suc-
cinate/malate antiporters are two separate yeast translocators.
Interestingly, externally added fumarate failed to cause e¥ux
of phosphate outside SCM, thus excluding the possibility that
malate e¥ux is the result of the combined actions of the
fumarate/phosphate and the phosphate/malate antiporters as
considered in [6].
A proposal about the existence of the succinate/fumarate
translocator has been made recently [19,20]. However, its sen-
sitivity towards inhibitor, even though measured under com-
pletely di¡erent conditions, appears to exclude that the pro-
posed succinate/fumarate carrier is the fumarate/malate
antiporter. Consistently, we exclude that succinate/malate
could be a result of the combined action of the proposed
succinate/fumarate and the fumarate/malate translocators.
The physiological role of the novel fumarate/malate trans-
locator can be only a matter of speculation: we could assume
that this carrier could be involved in the cytosolic purine
biosynthesis and in the arginine metabolism [21,22]. However,
this point is still to be investigated.
Acknowledgements: The helpful co-operation of Michelina Iacovino
who participated as a student in this work is gratefully acknowledged.
This work was partially ¢nanced by a PRIN Bioenergetics and Mem-
brane Transport grant to S.P.
References
[1] La Noue, K.F. and Schoolwerth, A.C. (1984) in: Bioenergetics,
pp. 221^261, Elsevier, Amsterdam.
[2] Kramer, R. and Palmieri, F. (1992) in: Molecular Mechanisms in
Bioenergetics, pp. 359^384, Elsevier, Amsterdam.
[3] Guerin, B. (1991) in: Mitochondria, The Yeasts, 2nd edn., Vol.
4, pp. 541^600, Academic Press, New York.
[4] El Moualij, B., Duyckaerts, C., Lamotte-Brasseur, J. and Sluse,
F.E. (1997) Yeast 13, 573^581.
[5] Passarella, S., Fasano, E., Carrieri, S. and Quagliariello, E.
(1979) Biochem. Biophys. Res. Commun. 90, 498^505.
[6] Atlante, A., Passarella, S., Giannattasio, S. and Quagliariello, E.
(1985) Biochem. Biophys. Res. Commun. 132, 8^18.
[7] Passarella, S., Atlante, A., Barile, M. and Quagliariello, E. (1987)
Neurochem. Res. 12, 255^264.
[8] Atlante, A., Gagliardi, S. and Passarella, S. (1998) Biochem.
Biophys. Res. Commun. 243, 711^718.
[9] Passarella, S., Ostuni, A., Atlante, A. and Quagliariello, E. (1988)
Biochem. Biophys. Res. Commun. 156, 978^986.
[10] Perkins, M., Haslam, J.M. and Linnane, A.W. (1973) Biochem. J.
4, 923^934.
[11] Pallotta, M.L., Brizio, C., Fratianni, A., De Virgilio, C., Barile,
M. and Passarella, S. (1998) FEBS Lett. 428, 245^249.
[12] Lowry, O.H., Rosebrough, N.J., Farr, A.L. and Randall, R.J.
(1951) J. Biol. Chem. 193, 265^275.
[13] Gimpel, J.A., De Haan, E.J. and Tager, J.M. (1973) Biochim.
Biophys. Acta 292, 582^591.
[14] Valenti, D., Barile, M., Quagliariello, E. and Passarella, S. (1999)
FEBS Lett. 444, 291^295.
[15] Hill, R.L. and Bradshaw, R.A. (1969) Methods Enzymol. 13, 91^
99.
[16] Mitchell, P. and Moyle, J. (1969) Eur. J. Biochem. 9, 149^155.
[17] Halestrap, A. (1975) Biochem. J. 148, 85^96.
[18] Pastore, D., Trono, D. and Passarella, S. (1999) Plant Biosyst. (in
press).
[19] Palmieri, L., Lasorsa, F.M., De Palma, A., Palmieri, F., Run-
swich, M.J. and Walker, J.E. (1997) FEBS Lett. 417, 114^118.
[20] Bojunga, N., Kotter, P. and Entian, K.D. (1998) Mol. Gen.
Genet. 5, 453^461.
[21] Jauniaux, J.C., Urrestarazu, L.A. and Wiame, J.M. (1978)
J. Bacteriol. 133, 1096^1107.
[22] Soetens, O., Crabeel, M., El Moualij, B., Duyckaerts, C. and
Sluse, F. (1998) Eur. J. Biochem. 258, 702^709.
FEBS 22967 26-11-99
M.L. Pallotta et al./FEBS Letters 462 (1999) 313^316316
